Nucleus has raised a total of $17.5 million in funding, with a focus on assessing genetic risk and plans to expand its team and infrastructure.
Founders
Kian Sadeghi
Company Description
Nucleus Genomics is a genetic testing company focused on calculating a patient’s risk of certain diseases by using polygenic risk scores derived from genetic data uploaded by users.
Market
Genetic Testing
Location
United States
Coinvestors
Founders Fund, Adrian Aoun, Brent Saunders, Matteo Franceschetti